Journal of Clinical Pathology · 2026-06-18
TCRbeta1/TCRbeta2 (TRBC1/TRBC2) antibody pair for determining T-cell monotypia as a surrogate for clonality in formalin-fixed paraffin-embedded material
Phrase rank #2 · DOI 10.1136/jcp-2026-210684
Other observed topics
T-cell
Observed in 155 articles across 13 journals.
Latest share0.39%
Change vs baseline+0.11 pp
Months observed13
Latest monthJul 2026
Portfolio article share
Attention over this snapshot
13 monthly points
Journal breadth
Where it appears
- Journal for ImmunoTherapy of Cancer122
- Gut8
- BMJ Case Reports6
- Sexually Transmitted Infections4
- BMJ Neurology Open3
- Lupus Science & Medicine3
- European Journal of Hospital Pharmacy2
- Journal of Clinical Pathology2
- BMJ Connections Oncology1
- BMJ Oncology1
- BMJ Supportive & Palliative Care1
- Drug and Therapeutics Bulletin1
Co-occurrence
Explore nearby topics
Inspect the source signal
Article evidence
30 high-ranking examples
Journal for ImmunoTherapy of Cancer · 2026-06-08
VSIG4 suppresses antitumor T cell immunity via the SLC3A2-dependent metabolic–ionic checkpoint
Phrase rank #2 · DOI 10.1136/jitc-2025-013562
Journal for ImmunoTherapy of Cancer · 2026-04-12
Stem-like PD-1+TCF-1+ CD8+ T cells result from helpless priming and rely on CD4+ T-cell help to complete their cytotoxic effector differentiation
Phrase rank #2 · DOI 10.1136/jitc-2025-014041
Journal for ImmunoTherapy of Cancer · 2026-03-03
TCR sequencing in cancer immunology and immunotherapy: what, when, where, why, and how
Phrase rank #2 · DOI 10.1136/jitc-2025-013499
Journal for ImmunoTherapy of Cancer · 2026-01-20
Vδ1 T-cell subset appears to be responsive to PD-1 blockade therapy and is associated with survival in melanoma
Phrase rank #2 · DOI 10.1136/jitc-2024-011224
Journal for ImmunoTherapy of Cancer · 2025-11-04
1237 Integrated platforms for the preclinical evaluation of T-cell engagers
Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.1237
Journal for ImmunoTherapy of Cancer · 2025-11-04
1177 Forodesine has anticancer immunomodulatory properties through the adenosine pathway
Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.1177
Journal for ImmunoTherapy of Cancer · 2025-11-04
277 Proteome turnover dynamics analysis uncovers E3 ligases that enhance T-cell persistence during exhaustion
Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.0277
Journal for ImmunoTherapy of Cancer · 2025-10-23
Tumor-secreted AGR2 induces dendritic cell dysfunction and impairs immunotherapy efficacy in LKB1-deficient cancer
Phrase rank #2 · DOI 10.1136/jitc-2025-012710
Journal for ImmunoTherapy of Cancer · 2025-09-04
The spontaneous neoantigen-specific CD4+ T-cell response to a growing tumor is functionally and phenotypically diverse
Phrase rank #2 · DOI 10.1136/jitc-2025-012209
Sexually Transmitted Infections · 2026-06-05
OC78 T-cell mediated immune responses following recombinant HZ/su vaccine in people with HIV with different CD4+ T-cell count
Phrase rank #3 · DOI 10.1136/sextrans-ICAR-2026.68
Gut · 2026-02-11
Catch me if you can! Is there protection from HCV (re)infection?
Phrase rank #3 · DOI 10.1136/gutjnl-2025-337209
Journal for ImmunoTherapy of Cancer · 2026-01-28
DUSP22 dephosphorylates LGALS1 to enhance T cell-driven antitumor immunity
Phrase rank #3 · DOI 10.1136/jitc-2025-013142
Journal for ImmunoTherapy of Cancer · 2026-01-27
Targeting AKR1B1 reprograms tumor-associated macrophages to enhance antitumor immunity
Phrase rank #3 · DOI 10.1136/jitc-2025-014043
Journal for ImmunoTherapy of Cancer · 2025-12-03
NEAT1 is a therapeutic target for reversing T-cell exhaustion in bladder cancer
Phrase rank #3 · DOI 10.1136/jitc-2025-013733
Journal for ImmunoTherapy of Cancer · 2025-12-01
Age-related immune states and PD-1 blockade: mechanisms and strategies for the elderly
Phrase rank #3 · DOI 10.1136/jitc-2025-013783
Journal for ImmunoTherapy of Cancer · 2025-11-04
1183 HX111, a FIC OX40-mAb-VC-MMAE ADC for the treatment of lymphoma
Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.1183
Journal for ImmunoTherapy of Cancer · 2025-11-04
783 Oncogenic PLCG1 drives aberrant intra- and intercellular T cell activation
Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.0783
Journal for ImmunoTherapy of Cancer · 2025-11-04
219 Epigenetic priming with DNMT inhibitors enhances CAR T-cell efficacy in pediatric brain tumors
Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.0219
Journal for ImmunoTherapy of Cancer · 2025-11-04
1133 The short chain fatty acid butyrate modulates myeloid cell activation, CD8+ T-cell function and checkpoint expression
Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.1133
Journal for ImmunoTherapy of Cancer · 2025-11-04
889 Comprehensive characterization of RNDO-564, a first-in-class CD28 x Nectin-4 bispecific antibody for the treatment of solid tumors
Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.0889
BMJ Case Reports · 2025-09-08
Late relapse of extranodal NK/T-cell lymphoma presenting as an adrenal mass with suspected cardiac involvement
Phrase rank #3 · DOI 10.1136/bcr-2025-266672
Lupus Science & Medicine · 2026-07-15
Integrated immune profiling identifies a coordinated T-cell activation and inflammatory signature in SLE
Phrase rank #4 · DOI 10.1136/lupus-2026-002068
Journal for ImmunoTherapy of Cancer · 2026-07-03
Emergence of a mixed CAF population by FAP-CD3 T-cell engager limits therapeutic efficacy
Phrase rank #4 · DOI 10.1136/jitc-2025-014551
Journal for ImmunoTherapy of Cancer · 2026-05-21
Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort
Phrase rank #4 · DOI 10.1136/jitc-2025-013901
Journal for ImmunoTherapy of Cancer · 2025-12-30
MAVS/CMTM6 axis couples mitochondrial homeostasis to immunogenic senescence via CCL3-driven T-cell recruitment in renal carcinoma
Phrase rank #4 · DOI 10.1136/jitc-2025-011477
Journal for ImmunoTherapy of Cancer · 2025-11-04
322 Single-cell RNA sequencing of afamitresgene autoleucel indicates mechanisms of persistence and anti-tumor activity
Phrase rank #4 · DOI 10.1136/jitc-2025-SITC2025.0322
Journal for ImmunoTherapy of Cancer · 2025-11-04
265 Augmenting notch1 to enhance CD19-BBz CAR-T therapy
Phrase rank #4 · DOI 10.1136/jitc-2025-SITC2025.0265
Journal for ImmunoTherapy of Cancer · 2025-11-04
506 Immune cell composition analysis of ERVE-4 T-Cell receptor gene therapy infusion products in metastatic ccRCC: insights from a first-in-human trial
Phrase rank #4 · DOI 10.1136/jitc-2025-SITC2025.0506
Journal for ImmunoTherapy of Cancer · 2025-11-04
652 Combining the bispecific antibodies BNT327 (PD-L1xVEGF-A) and BNT314 (EpCAMx4–1BB) enhances T-cell mediated cytotoxicity and antitumor activity in preclinical studies
Phrase rank #4 · DOI 10.1136/jitc-2025-SITC2025.0652